|
|
| Phases of Development | Preclinical | IND | Phase I | Phase I/II | Phase II | Phase II/III | Pivotal | Phase III | Registration | Approved | Marketed |
|---|
| Autoimmune | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | Cancer | 11 | 0 | 20 | 7 | 18 | 1 | 1 | 5 | 3 | 1 | 9 | | Cardiovascular | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 5 | | Endocrine / Metabolic | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | | Inflammation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | | Neurology | 2 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | | Ophthalmic | 2 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
|
|
Products Targeting Tubulin